Professional Documents
Culture Documents
Part 1
The Cardiovascular System and Blood Vessels
The Heart
Cardiovascular Pathways and Features
Cardiovascular Disorders
Part 2
Blood, Red Blood Cells, Oxygen Transportation, and RBC Disorders
White Blood Cell Types and Disorders
Platelets, Their Functions, and Disorders
Blood Types and Transfusions
Part 3
Lymphatic System
Microbes, Pathogens, and Humans (Oh My!)
Immunity and its Defenses
Immunization and Antibodies
Immune System Complications and Disorders
Part 3
Lymphatic System
Microbes, Pathogens, and
Humans (Oh My!)
Immunity and its Defenses
Immunization and
Antibodies
Immune System
Complications and Disorders
C. Jejuni is a
spiral-shaped
bacteria
Salmonella is a rod-
shaped bacteria
Ebola Virus
“The range of sizes shown by
viruses, relative to those of other Pictures and verbiage from http://en.wikipedia.org/wiki/Ebola &
organisms and biomolecules.” http://en.wikipedia.org/wiki/Virus#Viruses_and_disease
Microbes, Pathogens, and
Description from Scheme of Influenza A virus replication Humans (Oh My!)
(NCBI): "A virion attaches to the host cell membrane via
HA and enters the cytoplasm by receptor-mediated A virus attaches to the host cell and
endocytosis (Step 1), thereby forming an endosome. A enters endocytosis. The capsid protein
cellular trypsin-like enzyme cleaves HA into products HA1 dissociates and the viral RNA is
and HA2 (not shown). HA2 promotes fusion of the virus transported to the nucleus. In the nucleus,
envelope and the endosome membranes. A minor virus the viral polymerase complexes transcribe
envelope protein M2 acts as a ion channel thereby making and replicate the RNA. Viral mRNAs
the inside of the virion more acidic. As a result, the major migrate to cytoplasm where they are
envelope protein M1 dissociates from the nucleocapsid and translated into protein. Then the newly
vRNPs are translocated into the nucleus (Step 2) via synthesized virions bud from infected cell.
interaction between NP and cellular transport machinery. In
the nucleus, the viral polymerase complexes transcribe
(Step 3a) and replicate (Step 3b) the vRNAs. Newly
synthesized mRNAs migrate to cytoplasm (Step 4) where
they are translated. Posttranslational processing of HA, NA,
and M2 includes transportation via Golgi apparatus to the
cell membrane (Step 5b). NP, M1, NS1 (nonstructural
regulatory protein - not shown) and NEP (nuclear export
protein, a minor virion component - not shown) move to the
nucleus (Step 5a) where bind freshly synthesized copies of
vRNAs. The newly formed nucleocapsids migrate into the
cytoplasm in a NEP-dependent process and eventually
interact via M1 with a region of the cell membrane where
HA, NA and M2 have been inserted (Step 6). Then the
newly synthesized virions bud from infected cell (Step 7).
NA destroys the sialic acid moiety of cellular receptors,
thereby releasing the progeny virions." Pictures and verbiage from http://en.wikipedia.org/wiki/Ebola &
http://en.wikipedia.org/wiki/Virus#Viruses_and_disease
Part 3
Lymphatic System
Microbes, Pathogens, and Humans (Oh My!)
Immunity and its Defenses
Immunization and Antibodies
Immune System Complications and Disorders
“Specific, or adaptive immunity is often sub-divided into two major types depending on how the
immunity was introduced. Natural immunity occurs through contact with a disease causing agent,
when the contact was not deliberate, whereas artificial immunity develops only through deliberate
actions. Both natural and artificial immunity can be further subdivided, depending on the amount of
time the protection lasts. Passive immunity is short lived, and usually lasts only a few months,
whereas protection via active immunity lasts much longer, and is sometimes life-long. The diagram
below summarizes these divisions of immunity... The innate system is present from birth and
protects an individual from pathogens regardless of experiences, whereas adaptive immunity
arises only after an infection or immunization and hence is "acquired" during life.”
Picture & verbiage from http://en.wikipedia.org/wiki/Immunity_%28medical%29
Immunity and its Defenses
Immunity is the defense that a body takes to fight disease, infection, and unwanted pathogen
invasion. The immune system does this two ways: the body builds barriers and produces an
inflammatory response.
Inflammatory Response
Barriers
• Histamine (chemical) released which promotes capillary
2. Skin and mucous dilation
membranes are a barrier
• Skin turns red and hot due to increase in blood flow.
3. Chemical secretions on WBCs also come to area due to blood flow increase
the skin, along with saliva
• Blood clotting takes place
and tears contain
antibacterial enzymes • Neutrophils and monocytes phagocytize pathogens
4. Microbes which presently • Pus is created if neutrophils die in large numbers. If they
live in the body aid in are overwhelmed they will secrete a chemical called
pathogen occupancy cytokines which attract more phagocytic cells, such as
macrophages (large phagocytic cell) and WBCs, to the
damaged area.
Skin
Tissue
This picture shows how a plasma cell fused with a cancer cell
produces hybridoma cells which manufacture the monoclonal
antibodies
“Macrophages have
identified a cancer
cell (the large,
spiky mass). Upon
fusing with the
cancer cell, the
macrophages
(smaller white
cells) will inject
toxins that kill the
tumor cell.
Immunotherapy for
the treatment of
cancer is an active
area of medical
research.”
Part 3
Lymphatic System
Microbes, Pathogens, and Humans (Oh My!)
Nonspecific and Specific Defenses
Immunization and Antibodies
Immune System Complications and Disorders
Picture from
http://cseserv.engr.scu.edu/StudentAccounts
/ENGR019Winter2002/MSaeed/ResearchPape
r.htm
Works Cited
"Alternative complement pathway." Wikipedia, The Free Encyclopedia. 3 Mar 2008, 17:49 UTC. Wikimedia Foundation, Inc. 5 Mar
2008
<http://en.wikipedia.org/w/index.php?title=Alternative_complement_pathway&oldid=195592598>.
"Bacteria." Wikipedia, The Free Encyclopedia. 6 Mar 2008, 16:19 UTC. Wikimedia Foundation, Inc. 6 Mar 2008 <
http://en.wikipedia.org/w/index.php?title=Bacteria&oldid=196307437>.
"Campylobacter." Wikipedia, The Free Encyclopedia. 5 Mar 2008, 02:31 UTC. Wikimedia Foundation, Inc. 6 Mar 2008
<http://en.wikipedia.org/w/index.php?title=Campylobacter&oldid=195951225>.
"Classical complement pathway." Wikipedia, The Free Encyclopedia. 18 Feb 2008, 17:34 UTC. Wikimedia Foundation, Inc. 5 Mar 2008
<http://en.wikipedia.org/w/index.php?title=Classical_complement_pathway&oldid=192341349>.
Disease Education. Alternative to Traditional Lupus Treatment. Accessed 6 Mar 2008.
<http://www.diseaseeducation.com/diseases/Lupus.php>.
"Ebola." Wikipedia, The Free Encyclopedia. 5 Mar 2008, 18:42 UTC. Wikimedia Foundation, Inc. 6 Mar 2008 <
http://en.wikipedia.org/w/index.php?title=Ebola&oldid=196089513>.
"Hay fever." Wikipedia, The Free Encyclopedia. 2 Mar 2008, 03:23 UTC. Wikimedia Foundation, Inc. 6 Mar 2008 <http://
en.wikipedia.org/w/index.php?title=Hay_fever&oldid=196924870>.
"Immunity (medical)." Wikipedia, The Free Encyclopedia. 6 Mar 2008, 02:38 UTC. Wikimedia Foundation, Inc. 6 Mar 2008 <http://
en.wikipedia.org/w/index.php?title=Immunity_%28medical%29&oldid=196197729>.
"Immunization." Wikipedia, The Free Encyclopedia. 5 Mar 2008, 17:29 UTC. Wikimedia Foundation, Inc. 6 Mar 2008
<http://en.wikipedia.org/w/index.php?title=Immunization&oldid=196810111>.
Mader, Sylvia S. Human Biology. New York: The McGraw-Hill Companies, Inc, 2008. Pages 121-141.
Marilia Cascalho, Jeffrey L. Platt. New Technologies for Organ Replacement and Augmentation. MAYO CLIN PROC. 2005;80:370-378.
Accessed 6 Mar 2008.
<http://www.mayoclinicproceedings.com/inside.asp?AID=866&UID=>.
"Salmonella." Wikipedia, The Free Encyclopedia. 5 Mar 2008, 17:36 UTC. Wikimedia Foundation, Inc. 6 Mar 2008 <
http://en.wikipedia.org/w/index.php?title=Salmonella&oldid=196075037>.
Woman to Woman. Detoxification: The Lymph System and your Health. 11 Jan 2008. Accessed 5 Mar 2008
<http://www.womentowomen.com/detoxification/default.aspx>.
Xenotransplantation: Is it Ethical? Accessed 6 Mar 2008.
<http://cseserv.engr.scu.edu/StudentAccounts/ENGR019Winter2002/MSaeed/ResearchPaper.htm>.